Navigation Links
Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Anthera's Investigational Novel Peptibody Agent
Date:12/14/2010

y to Evaluate the Efficacy, Safety, and Tolerability of A623 AdministRation in Subjects with Systemic Lupus Erythematosus), is designed to demonstrate that inhibition of both membrane bound and soluble BAFF with A-623 will improve patient clinical outcomes as measured by a composite SLE responder index. Lupus patients suffer from an inappropriate, chronic autoimmune response which often leads to severe skin rash, fatigue, joint pain, organ complications and cardiovascular disease.

About B-Cell Activating Factor (BAFF) and A-623

BAFF has been associated with a wide range of B-Cell mediated autoimmune diseases, including systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, multiple sclerosis, Sjogren's Syndrome, Graves' Disease and others. Multiple clinical studies with other BAFF antagonists recently have reported on BAFF's potential positive role in treating lupus and rheumatoid arthritis. Anthera is advancing its development of A-623, a broad inhibitor of BAFF, to expand its potential clinical utility in autoimmune diseases. A-623 is a novel fusion protein called a peptibody and is distinct from an antibody. Anthera owns worldwide rights to A-623 in all potential indications.

About Merck BioManufacturing Network

Merck BioManufacturing Network (known outside the USA and Canada as MSD BioManufacturing Network) is a full service CMO providing development and manufacturing services for biologics to pharmaceutical and biotechnology companies. It comprises the operations at Billingham, UK (formerly Avecia Biologics), and at Research Triangle Park, NC, USA (formerly Diosynth Biotechnology). Merck is known as MSD outside USA and Canada. For additional information about Merck BioManufacturing Network, please visit www.biomanufacturingnetwork.com.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company foc
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Announces Update Call Regarding Vial Problems
2. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
3. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
4. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
5. Anthera Pharmaceuticals to Present at Deutsche Bank Securities 35th Annual Health Care Conference
6. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
7. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
8. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
9. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
10. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
11. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Eli Lilly and Company (NYSE: LLY ) and Incyte ... June 11 to discuss data from the first two pivotal ... two trials, RA-BEACON and RA-BUILD, will be presented on June ... in Rome, Italy . The ... Time. The live audio webcast can be accessed through a ...
(Date:5/28/2015)... , May 28, 2015  The U.S. Department ... Orbit Medical Inc. and Rehab Medical Inc. to resolve ... with the filing of a whistleblower lawsuit by two ... sales representatives, under the direction of one of Orbit,s ... so that Orbit could obtain payment from Medicare for ...
(Date:5/28/2015)... , May 28, 2015 ... Testing Market - Size, Industry Analysis, Trends, Opportunities, Growth and ... reach $3.6 billion by 2020. The secondary syphilis testing ... 2020. Latin America , ... (LAMEA) market accounted for about 43% revenue share ...
Breaking Medicine Technology:Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 2Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 3Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare 4Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3
... Mich., Sept. 13, 2011 The University of Michigan Health ... clinical alarm and alert data from medical to communications devices, ... Children,s Hospital and Von Voigtlander Women,s Hospital. "Moving ... room to a much larger facility where beds are now ...
... CORTLANDT MANOR, N.Y., Sept. 13, 2011 Polymedco, Inc. ... Health, Inc., for distribution of its market leading automated ... help increase patient compliance rates and aid in the ... of the OC-Auto Micro 80; automated FIT analyzer; and ...
Cached Medicine Technology:New Hospitals to Implement New Communications Technology 2Polymedco, Inc., and Cardinal Health Sign Agreement for Distribution of Oncologic Diagnostic Test Kits to Acute Care Market 2
(Date:5/28/2015)... RI (PRWEB) May 28, 2015 As the ... beach to keep cool. It’s important to make safety a ... is sharing some swimming tips. , According to the Centers ... in the United States, not including boating incidents. Additionally, the ... death for children ages 1 to 4. , Amica ...
(Date:5/28/2015)... Lauderdale, Florida (PRWEB) May 28, 2015 ... Havlicek, and wife Beth, both Genesis Foundation Board of ... Annual John Havlicek Celebrity Fishing Tournament June 4-7. For ... this 4-day event benefitting The Genesis Foundation for children ... the cause. , The 34th John Havlicek Celebrity ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 The CEO ... announced a just launched blog series which provides analysis ... Hosted on the “R. Bruce Dalglish” profile on Blogger.com, ... R. Bruce Dalglish’s corporate experience. , “Throughout my ... workplace cultures have upon the overall success of businesses,” ...
(Date:5/28/2015)... 2015 Nidra Herbal Sleep Supplement features a ... body. A non-addictive supplement, Nidra Herbal Sleep Supplement is more ... will leave users with a real sense of wellbeing the ... Ayurveda, which translates as the “Science or Knowledge of Life”, ... and is a holistic system of knowledge which combines contemplation, ...
(Date:5/28/2015)... 2015 Baptist Medical Center Jacksonville has ... from acute stroke or other neurological conditions. , The ... a few in the country and the first in ... such as brain aneurysms. , “Baptist Health is ... patients who are impacted by stroke,” said Nicole Thomas, ...
Breaking Medicine News(10 mins):Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:The Genesis Foundation Prepares for Their Final Annual John Havlicek Celebrity Fishing Tournament 2Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3
... , HOUSTON , Feb. 8 ... technology are invited to visit the NASA Goes the Distance exhibit ... Expo at the Palmer Event Center. NASA,s exhibit will be open ... 10 a.m. to 6 p.m. Saturday . The exhibit will ...
... MONDAY, Feb. 8 (HealthDay News) -- Decreased handgrip strength in ... say. , In a new study, handgrip strength was measured ... group of 555 participants in the Netherlands. The researchers found ... a greater decline in strength over time, was associated with ...
... New York,s ... , ... February 8, 2010 -- As a proactive measure, New York City and the Environmental Protection ... with the support of personal injury attorneys. As reported by The New York Times ...
... , Feb. 8 Aton Pharma, Inc., a ... Richardson has joined the company as Vice President, Commercial ... Donald A. Fishbein assumes the same role for the ... Holdings LLC, Aton is focused on the development and commercialization ...
... , , , , , ... Feb. 8 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. (Pink Sheet: ... botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM"), announced today,that it ... fiscal year ended, October 31, 2009 on time. In ...
... ... NuEarth Corporation (Pinksheets: NUEC) (“NuEarth”), a manufacturer and ... that the company’s Laboratory and Research Division “TerraSolv SA” has ... contract representing an additional $1.3 Million laboratory service contract with ...
Cached Medicine News:Health News:NASA Joins Austin Marathon Expo, Inspires Students 2Health News:Handgrip Strength Helps Predict Death Risk in Elderly 2Health News:New York Examines Possible Contamination in Public City Schools 2Health News:Aton Pharma Announces Michael H. Richardson to Head Orphan Drug Division 2Health News:Renhuang Reports Record Fiscal 2009 Results; Resumes Compliance With SEC Filing Requirements 2Health News:Renhuang Reports Record Fiscal 2009 Results; Resumes Compliance With SEC Filing Requirements 3Health News:NuEarth Signs $1.3 Million Laboratory Contract 2Health News:NuEarth Signs $1.3 Million Laboratory Contract 3
... and custom shields and barriers for superior radiation ... or high level radiation shielding, we have a ... lead acrylic, lead glass, lead vinyl or a ... offer shielding from 1/32" thick to 2" and ...
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre...
Wrap-Around, Full Protection Apron with BACK SUPPORT...
Medicine Products: